BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24094672)

  • 1. Quantitative assessment of lipiodol deposition after chemoembolization: comparison between cone-beam CT and multidetector CT.
    Chen R; Geschwind JF; Wang Z; Tacher V; Lin M
    J Vasc Interv Radiol; 2013 Dec; 24(12):1837-44. PubMed ID: 24094672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional evaluation of lipiodol retention in HCC after chemoembolization: a quantitative comparison between CBCT and MDCT.
    Wang Z; Lin M; Lesage D; Chen R; Chapiro J; Gu T; Tacher V; Duran R; Geschwind JF
    Acad Radiol; 2014 Mar; 21(3):393-9. PubMed ID: 24507426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
    Wang Z; Chen R; Duran R; Zhao Y; Yenokyan G; Chapiro J; Schernthaner R; Radaelli A; Lin M; Geschwind JF
    Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1548-56. PubMed ID: 26001366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cone-Beam Computed Tomography Correlates with Conventional Helical Computed Tomography in Evaluation of Lipiodol Accumulation in HCC after Chemoembolization.
    Ishikawa T; Abe S; Hoshii A; Yamada Y; Iiduka A; Nemoto T; Takeda K; Yoshida T
    PLoS One; 2016; 11(1):e0145546. PubMed ID: 26752696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipiodol retention pattern assessed by cone beam computed tomography during conventional transarterial chemoembolization of hepatocellular carcinoma: accuracy and correlation with response.
    Hu J; Maybody M; Cao G; Wang X; Chen H; Zhu X; Yang R; Wang X
    Cancer Imaging; 2016 Oct; 16(1):32. PubMed ID: 27716376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early prediction of 1-year tumor response of hepatocellular carcinoma with lipiodol deposition pattern through post-embolization cone-beam computed tomography during conventional transarterial chemoembolization.
    Tsai YC; Shih JH; Hwang HE; Chiu NC; Lee RC; Tseng HS; Liu CA
    Eur Radiol; 2021 Oct; 31(10):7464-7475. PubMed ID: 33765160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of Latest-generation Cone-beam Computed Tomography for Post Lipiodol-embolization Imaging in Hepatic Transarterial Chemoembolization in Comparison with Multi-detector Computed Tomography.
    Alizadeh LS; Koch V; Vogl TJ; Yel I; Gruenewald L; Albrecht MH; Herrmann E; von Knebel-Doeberitz PL; Booz C
    Acad Radiol; 2022 Jul; 29(7):e109-e118. PubMed ID: 34598867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between tumor perfusion and lipiodol deposition in hepatocellular carcinoma after transarterial chemoembolization.
    Yang L; Zhang XM; Zhou XP; Tang W; Guan YS; Zhai ZH; Dong GL
    J Vasc Interv Radiol; 2010 Dec; 21(12):1841-6. PubMed ID: 20980165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipiodol: a potential direct surrogate for cone-beam computed tomography image guidance in radiotherapy of liver tumor.
    Yue J; Sun X; Cai J; Yin FF; Yin Y; Zhu J; Lu J; Liu T; Yu J; Shi X; Song J
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):834-41. PubMed ID: 21377291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Automated Segmentation of Lipiodol Deposits on Cone-Beam CT Imaging Acquired during Transarterial Chemoembolization for Liver Tumors: A Deep Learning Approach.
    Malpani R; Petty CW; Yang J; Bhatt N; Zeevi T; Chockalingam V; Raju R; Petukhova-Greenstein A; Santana JG; Schlachter TR; Madoff DC; Chapiro J; Duncan J; Lin M
    J Vasc Interv Radiol; 2022 Mar; 33(3):324-332.e2. PubMed ID: 34923098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipiodol as an intra-procedural imaging biomarker for liver tumor response to transarterial chemoembolization: Post-hoc analysis of a prospective clinical trial.
    Letzen BS; Malpani R; Miszczuk M; de Ruiter QMB; Petty CW; Rexha I; Nezami N; Laage-Gaupp F; Lin M; Schlachter TR; Chapiro J
    Clin Imaging; 2021 Oct; 78():194-200. PubMed ID: 34022765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Efficacy of Cone-Beam CT-Based Liver Perfusion Mapping to Predict Initial Response of Hepatocellular Carcinoma to Transarterial Chemoembolization.
    Kim KA; Choi SY; Kim MU; Baek SY; Park SH; Yoo K; Kim TH; Kim HY
    J Vasc Interv Radiol; 2019 Mar; 30(3):358-369. PubMed ID: 30819478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
    Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
    World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual phase cone-beam computed tomography in detecting <3 cm hepatocellular carcinomas during transarterial chemoembolization.
    Wang X; Yarmohammadi H; Cao G; Ji X; Hu J; Yarmohammadi H; Chen H; Zhu X; Yang R; Solomon SB
    J Cancer Res Ther; 2017; 13(1):38-43. PubMed ID: 28508831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Establishing a Safety Margin Reduce Local Recurrence in Subsegmental Transarterial Chemoembolization for Small Nodular Hepatocellular Carcinomas?
    Kang HJ; Kim YI; Kim HC; Jae HJ; Hur S; Chung JW
    Korean J Radiol; 2015; 16(5):1068-78. PubMed ID: 26357501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodality 3D Tumor Segmentation in HCC Patients Treated with TACE.
    Wang Z; Chapiro J; Schernthaner R; Duran R; Chen R; Geschwind JF; Lin M
    Acad Radiol; 2015 Jul; 22(7):840-5. PubMed ID: 25863795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hug sign in intraprocedural cone-beam-CT to predict short-term response to combined treatment of hepatocellular carcinoma.
    Iezzi R; Posa A; Valente I; Contegiacomo A; Zocco MA; Pompili M; Annicchiarico BE; Ponziani FR; Basso M; Goldberg SN; Giuliante F; Gasbarrini A; Sala E;
    Radiol Med; 2024 May; 129(5):807-816. PubMed ID: 38512624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal measurement modality and method for evaluation of responses to transarterial chemoembolization of hepatocellular carcinoma based on enhancement criteria.
    Shim JH; Han S; Shin YM; Yu E; Park W; Kim KM; Lim YS; Lee HC
    J Vasc Interv Radiol; 2013 Mar; 24(3):316-25. PubMed ID: 23312990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angio-Computed Tomograph-Guided Immediate Lipiodol Computed Tomograph for Diagnosis of Small Hepatocellular Carcinoma Lesions during Transarterial Chemoembolization.
    Liu FY; Li X; Yuan HJ; Guan Y; Wang MQ
    Chin Med J (Engl); 2018 Oct; 131(20):2410-2416. PubMed ID: 30334525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated feature quantification of Lipiodol as imaging biomarker to predict therapeutic efficacy of conventional transarterial chemoembolization of liver cancer.
    Stark S; Wang C; Savic LJ; Letzen B; Schobert I; Miszczuk M; Murali N; Oestmann P; Gebauer B; Lin M; Duncan J; Schlachter T; Chapiro J
    Sci Rep; 2020 Oct; 10(1):18026. PubMed ID: 33093524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.